Tag: MORT

Benefits for cancer- and cardiovascular disease-specific mortality vanish with more than low levels of added sugar and saturated fat

Body fat percentage, waist circumference both significantly associated with 15-year all-cause mortality, heart disease mortality

While complications are low, they increase significantly with BMI ≥50

Decreases seen in mortality for acute MI, ischemic heart disease, while increases seen for mortality from other heart disease subtypes

Total adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function

Exposure to cyanobacterial harmful algal blooms linked to up to 0.89 years' shorter survival

Monthly DOD rate declined by −0.36 per 100,000 from August 2023 to February 2024, accelerating through October 2024

Incidence rates of composite of death, MI, stroke were lower, but not significantly so, for patients treated with semaglutide

Findings seen for both suicide and overall mortality, with even stronger effects seen in more recent studies

Increased estimated risk ratios seen for nonfatal acute coronary syndrome, stroke, cardiovascular death